Cite
HARVARD Citation
Takegawa, N. et al. (n.d.). DS‐8201a, a new HER2‐targeting antibody–drug conjugate incorporating a novel DNA topoisomerase I inhibitor, overcomes HER2‐positive gastric cancer T‐DM1 resistance. International journal of cancer. 141 (8), pp. 1682-1689. [Online].